Citations

Clear

60 citation(s) found for "Scharf, E".

Endovascular management of cerebral septic embolism: Three recent cases and review of the literature. (P3.299)
Chakraborty, Tia , Miranpuri, Amrendra, Scharf, Eugene , Rabinstein, Alejandro A.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 88 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.88.16_supplement.p3.299 Get It

Management of Chronic Subdural Hematoma in Patients Requiring Therapeutic Anticoagulation (2010)
Ighodaro, Eseosa T. , Brinjikji, Waleed , Cloft, Harry J. , Neth, Bryan J. , Scharf, Eugene

Mayo Clinic

Neurology | December 7, 2023 | Volume: 96 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.96.15_supplement.2010 Get It

The Fasting for Brain and Heart Health Study: Preliminary results (4618)
Myers, Toshia R. , Hwang, Su‐Yeon , Kolbe, Patricia, Scharf, Eugene

Mayo Clinic

Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.94.15_supplement.4618 Get It

The Endocannabinoid 2-arachidonoylglycerol (2-AG) Is Elevated In Acute Ischemic Stroke (1352)
Vasile, Vlad C. , Buciuc, Marina , Conte, Gian Marco , Scharf, Eugene

Mayo Clinic

Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.94.15_supplement.1352 Get It

The Effects of Prolonged Water-Only Fasting on Senescence Associated Secretory Phenotype (P2-3.005)
Zeiler, Evelyn , Myers, Toshia R. , Scharf, Eugene , Buciuc, Marina , Diniz, Breno Satler

Mayo Clinic

Neurology | December 6, 2023 | Volume: 98 | Issue: 18_supplement | Pages: No page available

10.1212/wnl.98.18_supplement.3172 Get It

Association of Cerebrovascular Imaging Biomarkers, Depression, and Anxiety, with Mild Cognitive Impairment
Vassilaki, Maria , Syrjanen, Jeremy A. , Krell‐Roesch, Janina , Graff‐Radford, Jonathan , Vemuri, Prashanthi , Fields, Julie A. , Kremers, Walter K. , Lowe, Val J. , Petersen, Ronald C. , Geda, Yonas E. , Vemuri, Prashanthi , Geda, Yonas E , Kremers, Walter K , Scharf, Eugene , Machulda, Mary M. , Jack, Clifford R. , Knopman, David S.

Mayo Clinic

Journal of Alzheimer's Disease Reports | November 3, 2023 | Volume: 7 | Issue: 1 | Pages: 1237-1246

10.3233/adr-230073 | PMID 38025797 Get It

The study included 1,738 Mayo Clinic Study of Aging participants (≥50 years old; 1,460 cognitively unimpaired and 278 with mild cognitive impairment (MCI)) and examined the cross-sectional association between cerebrovascular (CVD) imaging biomarkers (e.g., white matter hyperintensities (WMH), infarctions) and Beck Depression Inventory-II (BDI-II) and Beck Anxiety Inventory (BAI) scores, as well as their association with MCI. High (abnormal) WMH burden was significantly associated with having BDI-II>13 and BAI > 7 scores, and both (CVD imaging biomarkers and depression/anxiety) were significantly associated with MCI when included simultaneously in the model, suggesting that both were independently associated with the odds of MCI.
Utility of Protein Microarrays for Detection of Classified and Novel Antibodies in Autoimmune Neurologic Disease
Lesnick, Connie , Vorasoot, Nisa , Buckley, Monica , Dasari, Surendra , Gilligan, Michael , Lafrance-Corey, Reghann , Miske, Ramona , Pittock, Sean J. , Scharf, Madeleine, Yang, Binxia , Ζεκερίδου, Αναστασία , Dubey, Divyanshu , Mills, John R. , Pittock, S J , Lesnick, Connie , Vorasoot, Nisa , Buckley, Monica W , Dasari, Surendra , Gilligan, Michael , Lafrance-Corey, Reghann , Yang, Binxia , Dubey, Divyanshu , McKeon, Andrew , Flanagan, Eoin P.

Mayo Clinic

Neurology Neuroimmunology & Neuroinflammation | August 7, 2023 | Volume: 10 | Issue: 5 | Pages: No page available

10.1212/nxi.0000000000200145 | PMID 37550073 Get It

Abstract TP175: Age And Malignancy Associated With Positive Antiphospholipid Antibody Testing And Diagnosis In Embolic Stroke Of Undetermined Source Patients: A Retrospective Cohort Study
Liu, Michael , Griffin, Kim, Harahsheh, Ehab, Harahsheh, Ehab , Shahid, Adnan, Scharf, Eugene

Mayo Clinic

Stroke | February 2, 2023 | Volume: 54 | Issue: Suppl_1 | Pages: No page available

10.1161/str.54.suppl_1.tp175 Get It

Introduction: Embolic stroke of undetermined source (ESUS) is a clinical paradigm that helps to classify and lead investigations into cryptogenic stroke. Diagnostic evaluation of ESUS involves investigating several potential etiologies of stroke. One such etiology includes antiphospholipid syndrome (APLS), a syndrome known to cause hypercoagulability. Clinical characteristics of primary APLS in ESUS have not been described. Methods: This is an IRB approved, retrospective study including patients from 2015-2020 who were seen at Mayo Clinic, were diagnosed with ESUS, and had APLS testing (anti-cardiolipin, beta-2 glycoprotein, or lupus anticoagulant). Baseline characteristics and radiographic features were collected and compared between patients who were and were not diagnosed with APLS, as well as between patients who were and were not APLS antibody positive. Results: Our study included 206 patients. Positive APLS antibody testing was seen in 21 (10%) patients. Of those patients, 8 (4%) received a formal diagnosis of APLS. Compared to controls, patients with positive APLS antibodies as well as those diagnosed with APLS were more likely to have a history of cancer (20 [11%] APLS antibody negative vs 7 [33%] APLS antibody positive p=0.004) (23 [12%] APLS diagnosis negative vs 4 [50%] APLS diagnosis p=0.002). Mean age in primary APLS was greater, 57 years old APLS antibody negative vs 69 years old APLS antibody positive (p<0.001) and 58 years old APLS diagnosis negative vs 75 years old APLS diagnosis (p=0.001) (Table 1). Regressions analyses examining infarct topography and rate of hemorrhagic transformation were non-significant between groups (p>0.1) Conclusion: APLS presenting as ESUS is associated with older age and history of malignancy. We speculate this finding may underscore the need to consider hypercoagulable conditions more broadly in stroke evaluations of older populations. Larger cohorts and longer follow up will be required to validate this observation.
Interactions Between Neuropsychiatric Symptoms and Alzheimer's Disease Neuroimaging Biomarkers in Predicting Longitudinal Cognitive Decline
Pink, Anna , Krell‐Roesch, Janina , Syrjanen, Jeremy A. , Christenson, Luke R., Lowe, Val J. , Vemuri, Prashanthi , Fields, Julie A. , Petersen, Ronald C. , Vassilaki, Maria , Geda, Yonas E. , Vemuri, Prashanthi , Geda, Yonas E , Stokin, Gorazd B. , Kremers, Walter K. , Scharf, Eugene , Jack, Clifford R. , Knopman, David S.

Mayo Clinic

Psychiatric Research and Clinical Practice | January 21, 2023 | Volume: 5 | Issue: 1 | Pages: 4-15

10.1176/appi.prcp.20220036 | PMID 36909142 Get It